Baird’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Baird’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-17,012	Closed	-$310K	–	1171
2013 Q3	$310K	Buy	+17,012	New	+$307K	0.01%	924

Other funds holding AUXL

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

TCP

TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baird's AUXL Position: Q4 2013 in Review

Baird sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2013, closing a stake of 17,012 shares — an estimated $310K sold.

Baird first reported a position in AUXL in Q3 2013 and held it in 1 quarter. The position peaked at $310K in Q3 2013. 147 funds tracked by Wall St. Rank hold AUXL as of Q4 2013.

Baird reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2013 after selling out during the quarter.
Baird sold 17,012 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2013, an estimated $310K.
Baird first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q3 2013 and held it in 1 quarter.
Baird's AUXILIUM PHARAMCEUTICALS INC position peaked at $310K in Q3 2013.
147 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2013.

Based on Baird's 13F filing for Q4 2013, filed 12 Feb 2014.